nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—UGT1A1—urine—bipolar disorder	0.0261	0.0479	CbGeAlD
Erlotinib—ORM1—saliva—bipolar disorder	0.024	0.0441	CbGeAlD
Erlotinib—FLT3—blood plasma—bipolar disorder	0.0216	0.0396	CbGeAlD
Erlotinib—STK10—blood plasma—bipolar disorder	0.0144	0.0265	CbGeAlD
Erlotinib—UGT1A1—blood plasma—bipolar disorder	0.0136	0.025	CbGeAlD
Erlotinib—CYP1A2—urine—bipolar disorder	0.0116	0.0212	CbGeAlD
Erlotinib—AURKC—thyroid gland—bipolar disorder	0.0104	0.0192	CbGeAlD
Erlotinib—PIP4K2C—adrenal cortex—bipolar disorder	0.0099	0.0181	CbGeAlD
Erlotinib—JAK3—thyroid gland—bipolar disorder	0.00968	0.0177	CbGeAlD
Erlotinib—ULK3—adrenal cortex—bipolar disorder	0.00945	0.0173	CbGeAlD
Erlotinib—MKNK1—adrenal cortex—bipolar disorder	0.00889	0.0163	CbGeAlD
Erlotinib—TNK1—thyroid gland—bipolar disorder	0.00888	0.0163	CbGeAlD
Erlotinib—AURKC—nervous system—bipolar disorder	0.00879	0.0161	CbGeAlD
Erlotinib—SLK—adrenal cortex—bipolar disorder	0.00842	0.0154	CbGeAlD
Erlotinib—CYP3A4—urine—bipolar disorder	0.00837	0.0153	CbGeAlD
Erlotinib—CYP2D6—urine—bipolar disorder	0.00823	0.0151	CbGeAlD
Erlotinib—JAK3—nervous system—bipolar disorder	0.00814	0.0149	CbGeAlD
Erlotinib—EPHA6—nervous system—bipolar disorder	0.00814	0.0149	CbGeAlD
Erlotinib—HIPK4—brain—bipolar disorder	0.00787	0.0144	CbGeAlD
Erlotinib—LTK—brain—bipolar disorder	0.00778	0.0143	CbGeAlD
Erlotinib—JAK3—cerebellum—bipolar disorder	0.00766	0.014	CbGeAlD
Erlotinib—MAP3K19—nervous system—bipolar disorder	0.0074	0.0136	CbGeAlD
Erlotinib—ABL2—thyroid gland—bipolar disorder	0.00729	0.0134	CbGeAlD
Erlotinib—EGFR—thyroid gland—bipolar disorder	0.00711	0.013	CbGeAlD
Erlotinib—TNK1—cerebellum—bipolar disorder	0.00703	0.0129	CbGeAlD
Erlotinib—PIP4K2C—thyroid gland—bipolar disorder	0.00689	0.0126	CbGeAlD
Erlotinib—AURKC—brain—bipolar disorder	0.00672	0.0123	CbGeAlD
Erlotinib—ULK3—thyroid gland—bipolar disorder	0.00658	0.0121	CbGeAlD
Erlotinib—MAP2K5—adrenal cortex—bipolar disorder	0.00654	0.012	CbGeAlD
Erlotinib—CYP2C8—blood plasma—bipolar disorder	0.00645	0.0118	CbGeAlD
Erlotinib—JAK3—brain—bipolar disorder	0.00622	0.0114	CbGeAlD
Erlotinib—EPHA6—brain—bipolar disorder	0.00622	0.0114	CbGeAlD
Erlotinib—MKNK1—thyroid gland—bipolar disorder	0.0062	0.0114	CbGeAlD
Erlotinib—FLT3—cerebellum—bipolar disorder	0.00604	0.0111	CbGeAlD
Erlotinib—CYP1A2—blood plasma—bipolar disorder	0.00603	0.0111	CbGeAlD
Erlotinib—SLK—thyroid gland—bipolar disorder	0.00587	0.0108	CbGeAlD
Erlotinib—CYP3A5—blood plasma—bipolar disorder	0.00582	0.0107	CbGeAlD
Erlotinib—PIP4K2C—nervous system—bipolar disorder	0.0058	0.0106	CbGeAlD
Erlotinib—ABL2—cerebellum—bipolar disorder	0.00577	0.0106	CbGeAlD
Erlotinib—TNK1—brain—bipolar disorder	0.00571	0.0105	CbGeAlD
Erlotinib—MAP3K19—brain—bipolar disorder	0.00565	0.0104	CbGeAlD
Erlotinib—EGFR—cerebellum—bipolar disorder	0.00563	0.0103	CbGeAlD
Erlotinib—ULK3—nervous system—bipolar disorder	0.00554	0.0102	CbGeAlD
Erlotinib—PIP4K2C—cerebellum—bipolar disorder	0.00546	0.01	CbGeAlD
Erlotinib—MKNK1—nervous system—bipolar disorder	0.00521	0.00955	CbGeAlD
Erlotinib—ULK3—cerebellum—bipolar disorder	0.00521	0.00955	CbGeAlD
Erlotinib—STK10—thyroid gland—bipolar disorder	0.0051	0.00935	CbGeAlD
Erlotinib—ABL1—adrenal cortex—bipolar disorder	0.00505	0.00925	CbGeAlD
Erlotinib—MKNK1—cerebellum—bipolar disorder	0.0049	0.00899	CbGeAlD
Erlotinib—ABL2—brain—bipolar disorder	0.00468	0.00859	CbGeAlD
Erlotinib—SLK—cerebellum—bipolar disorder	0.00464	0.00851	CbGeAlD
Erlotinib—EGFR—brain—bipolar disorder	0.00457	0.00838	CbGeAlD
Erlotinib—MAP2K5—thyroid gland—bipolar disorder	0.00456	0.00835	CbGeAlD
Erlotinib—PIP4K2C—brain—bipolar disorder	0.00443	0.00813	CbGeAlD
Erlotinib—CYP3A4—blood plasma—bipolar disorder	0.00437	0.00801	CbGeAlD
Erlotinib—CYP2D6—blood plasma—bipolar disorder	0.0043	0.00788	CbGeAlD
Erlotinib—STK10—nervous system—bipolar disorder	0.00429	0.00787	CbGeAlD
Erlotinib—ULK3—brain—bipolar disorder	0.00423	0.00776	CbGeAlD
Erlotinib—STK10—cerebellum—bipolar disorder	0.00404	0.0074	CbGeAlD
Erlotinib—MKNK1—brain—bipolar disorder	0.00398	0.0073	CbGeAlD
Erlotinib—MAP2K5—nervous system—bipolar disorder	0.00383	0.00703	CbGeAlD
Erlotinib—SLK—brain—bipolar disorder	0.00377	0.00692	CbGeAlD
Erlotinib—MAP2K5—cerebellum—bipolar disorder	0.00361	0.00661	CbGeAlD
Erlotinib—SLCO2B1—thyroid gland—bipolar disorder	0.00355	0.0065	CbGeAlD
Erlotinib—ABL1—thyroid gland—bipolar disorder	0.00351	0.00644	CbGeAlD
Erlotinib—STK10—brain—bipolar disorder	0.00328	0.00601	CbGeAlD
Erlotinib—ABCG2—adrenal cortex—bipolar disorder	0.00318	0.00583	CbGeAlD
Erlotinib—ORM1—nervous system—bipolar disorder	0.00311	0.0057	CbGeAlD
Erlotinib—ABCB1—blood plasma—bipolar disorder	0.00309	0.00567	CbGeAlD
Erlotinib—SLCO2B1—nervous system—bipolar disorder	0.00298	0.00547	CbGeAlD
Erlotinib—CYP1B1—thyroid gland—bipolar disorder	0.00298	0.00546	CbGeAlD
Erlotinib—ABL1—nervous system—bipolar disorder	0.00296	0.00542	CbGeAlD
Erlotinib—MAP2K5—brain—bipolar disorder	0.00293	0.00537	CbGeAlD
Erlotinib—SLCO2B1—cerebellum—bipolar disorder	0.00281	0.00514	CbGeAlD
Erlotinib—ABL1—cerebellum—bipolar disorder	0.00278	0.0051	CbGeAlD
Erlotinib—CYP1B1—nervous system—bipolar disorder	0.0025	0.00459	CbGeAlD
Erlotinib—CYP1B1—cerebellum—bipolar disorder	0.00236	0.00432	CbGeAlD
Erlotinib—SLCO2B1—brain—bipolar disorder	0.00228	0.00418	CbGeAlD
Erlotinib—ABL1—brain—bipolar disorder	0.00226	0.00414	CbGeAlD
Erlotinib—ABCG2—thyroid gland—bipolar disorder	0.00222	0.00406	CbGeAlD
Erlotinib—CYP1A2—thyroid gland—bipolar disorder	0.00213	0.00391	CbGeAlD
Erlotinib—CYP1A1—thyroid gland—bipolar disorder	0.0021	0.00386	CbGeAlD
Erlotinib—ALB—brain—bipolar disorder	0.00209	0.00382	CbGeAlD
Erlotinib—CYP1B1—brain—bipolar disorder	0.00191	0.00351	CbGeAlD
Erlotinib—CYP1A1—nervous system—bipolar disorder	0.00177	0.00324	CbGeAlD
Erlotinib—ABCG2—cerebellum—bipolar disorder	0.00175	0.00322	CbGeAlD
Erlotinib—ABCB1—adrenal cortex—bipolar disorder	0.00157	0.00288	CbGeAlD
Erlotinib—CYP2C8—brain—bipolar disorder	0.00147	0.00269	CbGeAlD
Erlotinib—ABCG2—brain—bipolar disorder	0.00142	0.00261	CbGeAlD
Erlotinib—CYP1A1—brain—bipolar disorder	0.00135	0.00248	CbGeAlD
Erlotinib—CYP3A4—nervous system—bipolar disorder	0.0013	0.00238	CbGeAlD
Erlotinib—CYP2D6—nervous system—bipolar disorder	0.00128	0.00234	CbGeAlD
Erlotinib—CYP2D6—cerebellum—bipolar disorder	0.0012	0.0022	CbGeAlD
Erlotinib—ABCB1—thyroid gland—bipolar disorder	0.00109	0.002	CbGeAlD
Erlotinib—CYP2D6—brain—bipolar disorder	0.000977	0.00179	CbGeAlD
Erlotinib—ABCB1—nervous system—bipolar disorder	0.000919	0.00169	CbGeAlD
Erlotinib—ABCB1—cerebellum—bipolar disorder	0.000865	0.00159	CbGeAlD
Erlotinib—ABCB1—brain—bipolar disorder	0.000703	0.00129	CbGeAlD
Erlotinib—UGT1A1—Metabolism—PIK3C2A—bipolar disorder	0.000116	0.000255	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—INS—bipolar disorder	0.000116	0.000255	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AKR1C4—bipolar disorder	0.000116	0.000254	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—IMPA1—bipolar disorder	0.000115	0.000253	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AKR1C4—bipolar disorder	0.000115	0.000253	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NCAN—bipolar disorder	0.000115	0.000252	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—S100B—bipolar disorder	0.000114	0.00025	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CLOCK—bipolar disorder	0.000113	0.000249	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NR1D1—bipolar disorder	0.000113	0.000249	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-E—bipolar disorder	0.000113	0.000249	CbGpPWpGaD
Erlotinib—EGFR—Disease—SNAP25—bipolar disorder	0.000113	0.000248	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—SLC5A3—bipolar disorder	0.000112	0.000247	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000112	0.000245	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CACNA1C—bipolar disorder	0.000111	0.000244	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR2A—bipolar disorder	0.000111	0.000244	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—TSHB—bipolar disorder	0.00011	0.000243	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CACNB2—bipolar disorder	0.00011	0.000243	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—TPH2—bipolar disorder	0.00011	0.000243	CbGpPWpGaD
Erlotinib—ABL1—Immune System—S100B—bipolar disorder	0.00011	0.000243	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00011	0.000242	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—POMC—bipolar disorder	0.000109	0.00024	CbGpPWpGaD
Erlotinib—EGFR—Disease—GSK3A—bipolar disorder	0.000109	0.00024	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—DPYD—bipolar disorder	0.000109	0.000239	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NCAN—bipolar disorder	0.000108	0.000238	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ADCY2—bipolar disorder	0.000108	0.000238	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PIK3C2A—bipolar disorder	0.000108	0.000238	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000107	0.000235	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TRPC3—bipolar disorder	0.000106	0.000234	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SLC5A3—bipolar disorder	0.000106	0.000233	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—SNAP25—bipolar disorder	0.000104	0.000229	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NDUFV2—bipolar disorder	0.000104	0.000229	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NR1D1—bipolar disorder	0.000104	0.000228	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—GSK3B—bipolar disorder	0.000104	0.000228	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000104	0.000228	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NR1D1—bipolar disorder	0.000103	0.000227	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000103	0.000226	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL1B—bipolar disorder	0.000102	0.000224	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ADM—bipolar disorder	0.000101	0.000223	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CACNA1C—bipolar disorder	0.000101	0.000222	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AKR1C4—bipolar disorder	0.000101	0.000221	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NRG1—bipolar disorder	0.0001	0.000221	CbGpPWpGaD
Erlotinib—EGFR—Disease—ADCY2—bipolar disorder	9.99e-05	0.00022	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—GSK3B—bipolar disorder	9.96e-05	0.000219	CbGpPWpGaD
Erlotinib—EGFR—Disease—TCF7L2—bipolar disorder	9.96e-05	0.000219	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NCAN—bipolar disorder	9.93e-05	0.000218	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PDE4B—bipolar disorder	9.89e-05	0.000218	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TSHB—bipolar disorder	9.89e-05	0.000218	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TACR1—bipolar disorder	9.89e-05	0.000218	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NCAN—bipolar disorder	9.87e-05	0.000217	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PIK3C2A—bipolar disorder	9.84e-05	0.000217	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NDUFV2—bipolar disorder	9.79e-05	0.000215	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—IMPA1—bipolar disorder	9.76e-05	0.000215	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NRG1—bipolar disorder	9.74e-05	0.000214	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SLC5A3—bipolar disorder	9.73e-05	0.000214	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—SNAP25—bipolar disorder	9.7e-05	0.000213	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SLC5A3—bipolar disorder	9.67e-05	0.000213	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	9.54e-05	0.00021	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AKR1C4—bipolar disorder	9.49e-05	0.000209	CbGpPWpGaD
Erlotinib—EGFR—Immune System—S100B—bipolar disorder	9.43e-05	0.000207	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ADCY2—bipolar disorder	9.21e-05	0.000203	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	9.08e-05	0.0002	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NR1D1—bipolar disorder	9.04e-05	0.000199	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR2A—bipolar disorder	9.04e-05	0.000199	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	9.02e-05	0.000198	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—GSK3B—bipolar disorder	8.93e-05	0.000196	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—POMC—bipolar disorder	8.85e-05	0.000195	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—SNAP25—bipolar disorder	8.83e-05	0.000194	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—INS—bipolar disorder	8.81e-05	0.000194	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NCAN—bipolar disorder	8.65e-05	0.00019	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ADCY2—bipolar disorder	8.59e-05	0.000189	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NR1D1—bipolar disorder	8.52e-05	0.000187	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SLC5A3—bipolar disorder	8.47e-05	0.000186	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—POMC—bipolar disorder	8.42e-05	0.000185	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NRG1—bipolar disorder	8.32e-05	0.000183	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NDUFV2—bipolar disorder	8.3e-05	0.000183	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR2A—bipolar disorder	8.21e-05	0.000181	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR1A—bipolar disorder	8.19e-05	0.00018	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NCAN—bipolar disorder	8.15e-05	0.000179	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CLOCK—bipolar disorder	8.12e-05	0.000179	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TAC1—bipolar disorder	8.06e-05	0.000177	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AKR1C4—bipolar disorder	8.04e-05	0.000177	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SLC5A3—bipolar disorder	7.98e-05	0.000176	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—TPH2—bipolar disorder	7.91e-05	0.000174	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—TSHB—bipolar disorder	7.91e-05	0.000174	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CACNB2—bipolar disorder	7.91e-05	0.000174	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2C—bipolar disorder	7.91e-05	0.000174	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—DRD1—bipolar disorder	7.91e-05	0.000174	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—COMT—bipolar disorder	7.88e-05	0.000173	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MAOA—bipolar disorder	7.83e-05	0.000172	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ADCY2—bipolar disorder	7.81e-05	0.000172	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—DPYD—bipolar disorder	7.78e-05	0.000171	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NTRK2—bipolar disorder	7.69e-05	0.000169	CbGpPWpGaD
Erlotinib—EGFR—Disease—NRG1—bipolar disorder	7.68e-05	0.000169	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CLOCK—bipolar disorder	7.67e-05	0.000169	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—DRD3—bipolar disorder	7.66e-05	0.000168	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—GSK3A—bipolar disorder	7.62e-05	0.000168	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—IMPA1—bipolar disorder	7.53e-05	0.000166	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—TSHB—bipolar disorder	7.47e-05	0.000164	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—TPH2—bipolar disorder	7.47e-05	0.000164	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CACNB2—bipolar disorder	7.47e-05	0.000164	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—DRD4—bipolar disorder	7.43e-05	0.000164	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—COMT—bipolar disorder	7.35e-05	0.000162	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—DPYD—bipolar disorder	7.35e-05	0.000162	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MAOA—bipolar disorder	7.3e-05	0.000161	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	7.28e-05	0.00016	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CACNA1C—bipolar disorder	7.24e-05	0.000159	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NR1D1—bipolar disorder	7.22e-05	0.000159	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	7.22e-05	0.000159	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—INS—bipolar disorder	7.18e-05	0.000158	CbGpPWpGaD
Erlotinib—ABL1—Immune System—GSK3B—bipolar disorder	7.07e-05	0.000155	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	7.05e-05	0.000155	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CLOCK—bipolar disorder	7.03e-05	0.000155	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ADCY2—bipolar disorder	7e-05	0.000154	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CLOCK—bipolar disorder	6.99e-05	0.000154	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TCF7L2—bipolar disorder	6.97e-05	0.000153	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—DRD2—bipolar disorder	6.93e-05	0.000152	CbGpPWpGaD
Erlotinib—EGFR—Disease—MTHFR—bipolar disorder	6.92e-05	0.000152	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NCAN—bipolar disorder	6.9e-05	0.000152	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—TSHB—bipolar disorder	6.85e-05	0.000151	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—TPH2—bipolar disorder	6.85e-05	0.000151	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CACNB2—bipolar disorder	6.85e-05	0.000151	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CACNA1C—bipolar disorder	6.84e-05	0.00015	CbGpPWpGaD
Erlotinib—ALB—Metabolism—TSHB—bipolar disorder	6.81e-05	0.00015	CbGpPWpGaD
Erlotinib—ALB—Metabolism—TPH2—bipolar disorder	6.81e-05	0.00015	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CACNB2—bipolar disorder	6.81e-05	0.00015	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC5A3—bipolar disorder	6.76e-05	0.000149	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DPYD—bipolar disorder	6.74e-05	0.000148	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DPYD—bipolar disorder	6.7e-05	0.000147	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—COMT—bipolar disorder	6.69e-05	0.000147	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	6.66e-05	0.000147	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MAOA—bipolar disorder	6.64e-05	0.000146	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	6.57e-05	0.000145	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—POMC—bipolar disorder	6.56e-05	0.000144	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	6.4e-05	0.000141	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MTHFR—bipolar disorder	6.37e-05	0.00014	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—SNAP25—bipolar disorder	6.32e-05	0.000139	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NTRK1—bipolar disorder	6.27e-05	0.000138	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CACNA1C—bipolar disorder	6.27e-05	0.000138	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CACNA1C—bipolar disorder	6.23e-05	0.000137	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	6.2e-05	0.000136	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CLOCK—bipolar disorder	6.13e-05	0.000135	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	6.11e-05	0.000134	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—S100B—bipolar disorder	6.09e-05	0.000134	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PIK3C2A—bipolar disorder	6.07e-05	0.000134	CbGpPWpGaD
Erlotinib—EGFR—Immune System—GSK3B—bipolar disorder	6.04e-05	0.000133	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	6.03e-05	0.000133	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.99e-05	0.000132	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SNAP25—bipolar disorder	5.98e-05	0.000131	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—TSHB—bipolar disorder	5.97e-05	0.000131	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—TPH2—bipolar disorder	5.97e-05	0.000131	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CACNB2—bipolar disorder	5.97e-05	0.000131	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MTHFR—bipolar disorder	5.94e-05	0.000131	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DPYD—bipolar disorder	5.87e-05	0.000129	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CLOCK—bipolar disorder	5.77e-05	0.000127	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—TSHB—bipolar disorder	5.63e-05	0.000124	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—TPH2—bipolar disorder	5.63e-05	0.000124	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CACNB2—bipolar disorder	5.63e-05	0.000124	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ADCY2—bipolar disorder	5.6e-05	0.000123	CbGpPWpGaD
Erlotinib—EGFR—Disease—GSK3B—bipolar disorder	5.58e-05	0.000123	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NR1D1—bipolar disorder	5.57e-05	0.000123	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DPYD—bipolar disorder	5.53e-05	0.000122	CbGpPWpGaD
Erlotinib—EGFR—Disease—INS—bipolar disorder	5.5e-05	0.000121	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SNAP25—bipolar disorder	5.48e-05	0.000121	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CACNA1C—bipolar disorder	5.46e-05	0.00012	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SNAP25—bipolar disorder	5.45e-05	0.00012	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MTHFR—bipolar disorder	5.41e-05	0.000119	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NRG1—bipolar disorder	5.38e-05	0.000118	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NCAN—bipolar disorder	5.33e-05	0.000117	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	5.32e-05	0.000117	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ADCY2—bipolar disorder	5.29e-05	0.000116	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	5.22e-05	0.000115	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—bipolar disorder	5.2e-05	0.000114	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CACNA1C—bipolar disorder	5.15e-05	0.000113	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—bipolar disorder	5.1e-05	0.000112	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—INS—bipolar disorder	5.07e-05	0.000112	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	5.01e-05	0.00011	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CLOCK—bipolar disorder	4.89e-05	0.000108	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2A—bipolar disorder	4.85e-05	0.000107	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ADCY2—bipolar disorder	4.85e-05	0.000107	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ADCY2—bipolar disorder	4.82e-05	0.000106	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—COMT—bipolar disorder	4.79e-05	0.000105	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SNAP25—bipolar disorder	4.77e-05	0.000105	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TSHB—bipolar disorder	4.77e-05	0.000105	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TPH2—bipolar disorder	4.77e-05	0.000105	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CACNB2—bipolar disorder	4.77e-05	0.000105	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MAOA—bipolar disorder	4.76e-05	0.000105	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—bipolar disorder	4.75e-05	0.000105	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—INS—bipolar disorder	4.73e-05	0.000104	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DPYD—bipolar disorder	4.69e-05	0.000103	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—COMT—bipolar disorder	4.53e-05	9.96e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SNAP25—bipolar disorder	4.5e-05	9.89e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MAOA—bipolar disorder	4.5e-05	9.89e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—bipolar disorder	4.45e-05	9.78e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CACNA1C—bipolar disorder	4.36e-05	9.59e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—bipolar disorder	4.32e-05	9.51e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—INS—bipolar disorder	4.3e-05	9.46e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	4.25e-05	9.34e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADCY2—bipolar disorder	4.22e-05	9.29e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.19e-05	9.22e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—COMT—bipolar disorder	4.15e-05	9.13e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—COMT—bipolar disorder	4.13e-05	9.08e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MAOA—bipolar disorder	4.12e-05	9.07e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MAOA—bipolar disorder	4.1e-05	9.02e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADCY2—bipolar disorder	3.98e-05	8.76e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—GSK3B—bipolar disorder	3.9e-05	8.59e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MTHFR—bipolar disorder	3.87e-05	8.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—bipolar disorder	3.87e-05	8.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—INS—bipolar disorder	3.85e-05	8.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SNAP25—bipolar disorder	3.81e-05	8.38e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CLOCK—bipolar disorder	3.77e-05	8.3e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TPH2—bipolar disorder	3.68e-05	8.09e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TSHB—bipolar disorder	3.68e-05	8.09e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CACNB2—bipolar disorder	3.68e-05	8.09e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MTHFR—bipolar disorder	3.66e-05	8.05e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DPYD—bipolar disorder	3.62e-05	7.96e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—COMT—bipolar disorder	3.62e-05	7.96e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MAOA—bipolar disorder	3.59e-05	7.9e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—COMT—bipolar disorder	3.41e-05	7.5e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MAOA—bipolar disorder	3.38e-05	7.45e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADCY2—bipolar disorder	3.37e-05	7.42e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	3.36e-05	7.4e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—bipolar disorder	3.36e-05	7.38e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—bipolar disorder	3.34e-05	7.34e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	3.28e-05	7.21e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—bipolar disorder	3.1e-05	6.82e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—INS—bipolar disorder	3.08e-05	6.78e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SNAP25—bipolar disorder	2.94e-05	6.47e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—bipolar disorder	2.93e-05	6.44e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—bipolar disorder	2.92e-05	6.43e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—INS—bipolar disorder	2.91e-05	6.4e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—COMT—bipolar disorder	2.89e-05	6.35e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MAOA—bipolar disorder	2.87e-05	6.31e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—bipolar disorder	2.76e-05	6.06e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—bipolar disorder	2.68e-05	5.9e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—INS—bipolar disorder	2.67e-05	5.87e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—bipolar disorder	2.67e-05	5.87e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—INS—bipolar disorder	2.65e-05	5.84e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADCY2—bipolar disorder	2.6e-05	5.72e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—bipolar disorder	2.34e-05	5.14e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—bipolar disorder	2.33e-05	5.13e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—INS—bipolar disorder	2.33e-05	5.12e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—COMT—bipolar disorder	2.23e-05	4.9e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MAOA—bipolar disorder	2.21e-05	4.87e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—bipolar disorder	2.2e-05	4.85e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—INS—bipolar disorder	2.19e-05	4.82e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—bipolar disorder	1.87e-05	4.11e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—INS—bipolar disorder	1.86e-05	4.08e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—bipolar disorder	1.8e-05	3.96e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—bipolar disorder	1.44e-05	3.17e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—INS—bipolar disorder	1.43e-05	3.15e-05	CbGpPWpGaD
